corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 1333

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Bzdek V.
Tube Feeding: Health 'Education' Programs Are Beamed to the Hospital Bed by the Patient Channel. Some Critics Can't Swallow the Added Dose of Drug Company Promotion
Washington Post 2003 Jul 8


Full text:

“Cholesterol, Issues and Answers,” Scene 1: Fade in on a Recovering Heart Patient, sixtyish and slightly disheveled, as he talks frankly about all he did wrong before his bypass. Ate wrong. Drank wrong. Didn’t exercise. Never paid attention to his triglycerides or cholesterol, good or bad.

Contritely, he tells the camera: “If I have to take a pill once a day to keep my cholesterol down, I can live with that.”

Cut to Program Host, an authoritative yet kindly Anthony Edwards figure. Exuding reassurance, he lists the many benefits of lowering your cholesterol with diet, exercise and medicine.

Dissolve to Vibrant, Smiling Woman in Her Seventies, another recovered heart patient, who is planting flowers in a leafy suburban back yard. In voiceover, she describes how the prescription drug Plavix has helped prevent her heart problems from recurring.

“Taking Plavix once a day helps protect me,” she says.

Two Cute Grandchildren run up for a hug, and she squirts them playfully with the garden hose. Shrieks, smiles, dappled sunshine. And fade.

Following “Cholesterol” in tonight’s program lineup:

  • “Asthma: One Breath at a Time,”
  • “Rhythms of the Heart: Advances in Arrhythmias,” and then that noir classic,
  • “Irritable Bowel Syndrome: Breaking the Secrecy Barrier.”

Introducing the Patient Channel, coming soon to a hospital near you — unless activists worried about the marketing of drugs to bedridden patients succeed in pulling its plug.

The year-old broadcasting venture by General Electric features a 24-hour slate of half-hour education programs on such topics as cancer, diabetes and heart disease — punctuated by advertisements for prescription drugs and other medical services. GE says the idea behind the enterprise is to give hospital patients timely treatment information presented with just a dash of Hollywood razzle-dazzle.

“The one place in the world you couldn’t get good health information was in the hospital,” said Bruce Dan, a Bethesda internist who is managing editor of the Patient Channel. “Now there are smarter patients and better patients.”

However, the 800 hospitals that carry the network — including Walter Reed Army Medical Center in the District and Inova Fair Oaks in Fairfax — don’t pay for the broadcasts, which are transmitted via satellite and shown on hospital-owned TVs in patient rooms and waiting rooms. All Patient Channel costs are paid by pharmaceutical and medical services companies that advertise on the network. The Patient Channel, they say, is the logical next step in their push to market directly to consumers.

But the move has triggered a backlash among some hospitals, doctors and consumer advocates, who say a hospital is no place to be selling drugs. The fight is one of the newest flashpoints of a larger battle over the limits of commercial and corporate access to once-protected public and private spheres.

“The Patient Channel turns a hospital into a huckster for drugs when it should be a place people go to heal,” says Gary Ruskin, co-founder of Commercial Alert, a Ralph Nader-led nonprofit group leading the attack. “It’s gulling the sick in their hospital beds.”

Others argue that ads aimed at a hospital’s captive audience help drive up drug costs because patients insist on more expensive medications that may not be much more effective than less-advertised drugs. A recent study by researchers at Harvard University and the Massachusetts Institute of Technology found that direct-to-consumer marketing was responsible for 12 percent of the increase in prescription drug sales, or an additional $2.6 billion, in 2000.

“This is an extreme example of where we’re going in the confusion of commerce, health and education,” says Marcia Angell, senior lecturer for the Department of Social Medicine at Harvard Medical School and former editor of the New England Journal of Medicine. “Twenty years ago it was just called health care. Now it’s the health care ‘industry.’ I’m not sure that’s a good development.”

Medium vs. Message
But is the Patient Channel really such a departure?

After all, a one-hour stretch of programming contains only two to three minutes of recognizable product advertising, far less than the amount shown on regular TV networks, said Patrick Jarvis, spokesman for the Patient Channel.

All the ads, he said, have been approved by the Food and Drug Administration. And it’s not as if the sell is harder. Notes Dan, “When you’re in the hospital, you see the same exact ads on other channels.”

What then is all the fuss about? The problem, say opponents, is the confusion created for vulnerable patients when the ads are presented in a hospital context.

“When you’re a hospital, you’re taken as the health care source for patients . . . or even in the community,” said Mary Ann Ninnis, spokeswoman for Universal Health Services (UHS), one of three major hospital chains that decided in April against subscribing to the Patient Channel. (UHS oversees 100 hospitals. Catholic Healthcare East and Catholic Healthcare West, which also turned down the Patient Channel, operate 94 and 42 hospitals, respectively.)

Patients, said Ninnis, could see the services advertised on the Patient Channel “as something they are supposed to do versus having choice. That’s why it is basically our policy not to permit outside sources to provide information that could influence a patient’s thinking. You have to be very careful . . . and not even give a whisper of a preference. They need to make their decision on their own.”

Commercial Alert, founded five years ago to oppose “the excesses of commercialism, advertising and marketing,” mailed letters in February to the CEOs of 60 U.S. hospital chains, urging them to stop GE from reaching its goal of installing the Patient Channel in 1,100 hospitals this year.

But since the Commercial Alert challenge, the number of hospitals signing up for the network has spiked, said Dan, a former senior editor of the Journal of the American Medical Association and former medical editor of ABC News.

“We’ve had some hospitals call us back and say, ‘We can’t stand Ralph Nader. We’d like to sign up,’ “ he said.

Bill Swisher, spokesman for Walter Reed, said the staff is pleased with the service, and Reed’s patient education coordinator found the content “excellent.” “We think it’s a useful source of information for our patients,” Swisher said. Not a single Walter Reed patient has complained about the network. “In fact, we’ve had compliments on it from our patients and our own staff,” Swisher added. “We have confidence in the ability of our patients to distinguish between the programming and the commercials.”

Jarvis speculates that Commercial Alert has singled out the Patient Channel precisely because it is so successful. “It’s a standard practice of small, low-budget activist groups,” Jarvis said. “They pick a big fish to target to get publicity for their cause.”

The Nature of Education
Lately, however, the agency that accredits hospitals has taken an interest in the Patient Channel. A key area of attention: one of the Patient Channel’s main selling points to hospitals. Until late June, marketing materials created by GE Medical Systems, the corporate unit that operates the Patient Channel, told hospitals that its programs helped fulfill national standards for patient education.

Those standards require “that a patient receive education and training specific to the patient’s assessed needs, abilities, learning preferences and readiness to learn, as appropriate to the care and services provided by the hospital.” But on April 24, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) informed Patient Channel executives that the programs in no way meet its requirements for patient education. Patient Channel programming, said Robert Wise, vice president of standards for JCAHO, is one-size-fits-all, and individual patient needs are not addressed. Tailoring education to those specific needs is at the heart of JCAHO requirements. Wise said Patient Channel officials promised to remove any statement about joint commission standards from future marketing materials.

Accreditation standards aside, Patient Channel officials insist the programming provides real education, noting that several of the programs have been produced at the request of hospitals; others have been produced in collaboration with reputable medical organizations. For example, “Living with Cancer” was produced with the cooperation of the National Cancer Institute (NCI), which helped producers outline topic areas, develop the script and find experts to interview, Dan says. NCI will also review the final program, according to Dan, for “accuracy, currency, objectivity and completeness.”

Other reviewers will include the same three advisory boards that regularly vet Patient Channel programs — a medical advisory board, an ethics, legal and regulatory board, and a hospital advisory board — all including prominent doctors and medical professionals, says Dan. The reviewers, except for those on the hospital advisory board, will be paid a stipend by the Patient Channel, he adds.

One of the programs that appears regularly is “HealthWeek,” which is produced by Newsweek Productions in association with Maryland Public Television and washingtonpost.com.

Angell isn’t buying the education rationale. “The notion that pharmaceutical companies can educate patients and doctors is absurd,” she says. “For some reason, pharmaceutical companies are getting a pass on this.” She doesn’t see much difference between the programming and the advertising since drug companies are paying for both. “It’s all advertising,” she said.

In his April letter to the Patient Channel, Dennis O’Leary, president of JCAHO, warned that patients may not be able to distinguish between the programming and the marketing, and he urged GE to add “prominent disclaimers” to its programming that say the hospital does not endorse the products or services mentioned. He asked hospitals that air the channel to carefully review their ethics policies for potential conflict-of-interest problems.

In response, Patient Channel officials have agreed to more clearly delineate between ads and programming.

Ruskin said that’s not enough. “The name implies that it is a product of the hospital. That’s very different from other television stations. ‘I Love Lucy’ does not imply that it is a product of the hospital and its doctors.”

Ruskin says allowing advertisers to pitch products to patients under the guise of education is a case of the fox guarding the henhouse. “Anyone who broadcasts to an audience of the sick and vulnerable has a heightened responsibility not to deceive or mislead. That is especially true of drug ads, because even when drugs are used properly, they may cause death or serious illness.”*

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend